BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 30204866)

  • 21. The C1q/TNF-related proteins (CTRPs) in pathogenesis of obesity-related metabolic disorders: Focus on type 2 diabetes and cardiovascular diseases.
    Shanaki M; Shabani P; Goudarzi A; Omidifar A; Bashash D; Emamgholipour S
    Life Sci; 2020 Sep; 256():117913. PubMed ID: 32526287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Role of Ghrelin in Senescence: A Mini-Review.
    Yin Y; Zhang W
    Gerontology; 2016; 62(2):155-62. PubMed ID: 26160147
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Insulin action in the brain: Roles in energy and glucose homeostasis.
    Dodd GT; Tiganis T
    J Neuroendocrinol; 2017 Oct; 29(10):. PubMed ID: 28758251
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Carbohydrate metabolism, insulin resistance, and metabolic cardiovascular syndrome.
    Vaaler S
    J Cardiovasc Pharmacol; 1992; 20 Suppl 8():S11-4. PubMed ID: 1283763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease].
    Kravchun P; Kadykova O; Gabisoniia T
    Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The metabolic syndrome].
    Internist (Berl); 1995 May; 36(5 Suppl Metabolisc):1-12. PubMed ID: 9403089
    [No Abstract]   [Full Text] [Related]  

  • 27. Atypical antipsychotics and glucose homeostasis.
    Bergman RN; Ader M
    J Clin Psychiatry; 2005 Apr; 66(4):504-14. PubMed ID: 15816794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of insulin resistance in the pathophysiology of non-insulin dependent diabetes mellitus.
    Reaven GM
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():5S-12S. PubMed ID: 8299489
    [No Abstract]   [Full Text] [Related]  

  • 29. Emerging role of the brain in the homeostatic regulation of energy and glucose metabolism.
    Roh E; Song DK; Kim MS
    Exp Mol Med; 2016 Mar; 48(3):e216. PubMed ID: 26964832
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Can 14-3-3 proteins serve as therapeutic targets for the treatment of metabolic diseases?
    Diallo K; Oppong AK; Lim GE
    Pharmacol Res; 2019 Jan; 139():199-206. PubMed ID: 30453034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. G protein-coupled receptors in energy homeostasis.
    Wang J; Xiao R
    Sci China Life Sci; 2014 Jul; 57(7):672-80. PubMed ID: 24969703
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetes and apoptosis: liver.
    Schattenberg JM; Schuchmann M
    Apoptosis; 2009 Dec; 14(12):1459-71. PubMed ID: 19544096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is Mitochondrial Dysfunction a Common Root of Noncommunicable Chronic Diseases?
    Diaz-Vegas A; Sanchez-Aguilera P; Krycer JR; Morales PE; Monsalves-Alvarez M; Cifuentes M; Rothermel BA; Lavandero S
    Endocr Rev; 2020 Jun; 41(3):. PubMed ID: 32179913
    [TBL] [Abstract][Full Text] [Related]  

  • 34. mTORC1 signaling in energy balance and metabolic disease.
    Catania C; Binder E; Cota D
    Int J Obes (Lond); 2011 Jun; 35(6):751-61. PubMed ID: 20877289
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Over-nutrient environment during both prenatal and postnatal development increases severity of islet injury, hyperglycemia, and metabolic disorders in the offspring.
    Li L; Xue J; Li H; Ding J; Wang Y; Wang X
    J Physiol Biochem; 2015 Sep; 71(3):391-403. PubMed ID: 26048534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PHLPP: a putative cellular target during insulin resistance and type 2 diabetes.
    Mathur A; Pandey VK; Kakkar P
    J Endocrinol; 2017 Jun; 233(3):R185-R198. PubMed ID: 28428363
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic and Cardiovascular Actions of Nesfatin-1: Implications in Health and Disease.
    Ramesh N; Gawli K; Pasupulleti VK; Unniappan S
    Curr Pharm Des; 2017; 23(10):1453-1464. PubMed ID: 28137218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Polyunsaturated fatty acids, membrane function and metabolic diseases such as diabetes and obesity.
    Storlien LH; Hulbert AJ; Else PL
    Curr Opin Clin Nutr Metab Care; 1998 Nov; 1(6):559-63. PubMed ID: 10565410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glycerolipid/free fatty acid cycle and islet β-cell function in health, obesity and diabetes.
    Prentki M; Madiraju SR
    Mol Cell Endocrinol; 2012 Apr; 353(1-2):88-100. PubMed ID: 22108437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.